Nuage Therapeutics
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Carrer De Baldiri Reixac 10-12, Barcelon...Website
www.nuagetx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Nuage Therapeutics
Nuage Therapeutics is focused on developing transformative precision therapies for aggressive cancers by targeting intrinsically disordered proteins that are typically resistant to conventional drug discovery methods. The company is pioneering a novel approach to drug discovery that leverages the unique properties of disordered proteins to identify new oncology targets. In addition to cancer, Nuage's technology has potential applications in other therapeutic areas such as neurodegenerative diseases and autoimmune disorders. Their commitment to innovation positions them at the forefront of a new wave of drug development.Explore more
Nuage Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nuage Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nuage Therapeutics launches new products
Click to see if Nuage Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Nuage Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Nuage Therapeutics has new funding data
Check out if Nuage Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Nuage Therapeutics
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Nuage Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Nuage Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Nuage Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Nuage Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nuage Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nuage Therapeutics.
Nuage Therapeutics financials insights
Gather financial insights about Nuage Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Unspecified
$3.1M
Nuage Therapeutics Tech Stack
A closer look at the technologies used by Nuage Therapeutics
See more technologies
Most Recent Scoops
Funding
Funding
Left Company
Executive Move
Executive Moves, Left Company
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
Nuage Therapeutics News & Media
Nuage Therapeutics appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair
BARCELONA, Spain--(BUSINESS WIRE)--Nuage Therapeutics, a biotech company creating transformational precision therapies, has appointed Stuart Hughes as CEO and Vanessa Malier as Chair.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nuage Therapeutics
Sign Up For FreeTo access detailed company insights
Nuage Therapeutics is focused on developing transformative precision therapies for aggressive cancers by targeting intrinsically disordered proteins that are typically resistant to conventional drug discovery methods. The company is pioneering a novel approach to drug discovery that leverages the unique properties of disordered proteins to identify... Read More
